BACKGROUND:Asymptomatic cerebral lesions (ACL) may occur during atrial fibrillation (AF) ablation. We sought to compare the ACL incidence between 3 contemporary technologies: (1) irrigated radiofrequency current (RFC), (2) the single big cryoballoon (CB), and (3) the endoscopic laser-balloon (LB) in a prospective randomized pilot study. METHODS AND RESULTS:Ninety-nine patients were treated in 3 groups. Diffusion weighted MRI was acquired pre- (n = 20) and 24-48 h postablation (n = 99). After ablation, new ACL were detected in 22% of patients without significant differences between groups (RFC 8/33; CB 6/33; LB 8/33; P = 0.8). The presence of hypertension was identified as the only independent predictor of ACL by univariate regression analysis. During LB ablation, more ablation lesions (140 ± 19 vs 119 ± 18; P = 0.007) were applied during longer procedures (166 ± 36 vs 143 ± 32 min; P = 0.05) in patients with ACL. Univariate analysis revealed that a higher number of ablation lesions predicted ACL (P = 0.02). CONCLUSION: In this prospective, randomized, single-center pilot study, ablation technology did not influence the occurrence of ACL during AF ablation.
RCT Entities:
BACKGROUND: Asymptomatic cerebral lesions (ACL) may occur during atrial fibrillation (AF) ablation. We sought to compare the ACL incidence between 3 contemporary technologies: (1) irrigated radiofrequency current (RFC), (2) the single big cryoballoon (CB), and (3) the endoscopic laser-balloon (LB) in a prospective randomized pilot study. METHODS AND RESULTS: Ninety-nine patients were treated in 3 groups. Diffusion weighted MRI was acquired pre- (n = 20) and 24-48 h postablation (n = 99). After ablation, new ACL were detected in 22% of patients without significant differences between groups (RFC 8/33; CB 6/33; LB 8/33; P = 0.8). The presence of hypertension was identified as the only independent predictor of ACL by univariate regression analysis. During LB ablation, more ablation lesions (140 ± 19 vs 119 ± 18; P = 0.007) were applied during longer procedures (166 ± 36 vs 143 ± 32 min; P = 0.05) in patients with ACL. Univariate analysis revealed that a higher number of ablation lesions predicted ACL (P = 0.02). CONCLUSION: In this prospective, randomized, single-center pilot study, ablation technology did not influence the occurrence of ACL during AF ablation.
Authors: Giovanni B Forleo; Domenico G Della Rocca; Carlo Lavalle; Massimo Mantica; Lida P Papavasileiou; Valentina Ribatti; Germana Panattoni; Luca Santini; Andrea Natale; Luigi Di Biase Journal: J Atr Fibrillation Date: 2016-02-29
Authors: Tina Lin; Erik Wissner; Roland Tilz; Andreas Rillig; Shibu Mathew; Peter Rausch; Peter Rausch; Christine Lemes; Sebastian Deiss; Masashi Kamioka; Tudor Bucur; Feifan Ouyang; Karl-Heinz Kuck; Andreas Metzner Journal: J Atr Fibrillation Date: 2014-06-30
Authors: Thomas Deneke; Karin Nentwich; Joachim Krug; Patrick Müller; Peter Hubert Grewe; Andreas Mügge; Anja Schade Journal: J Atr Fibrillation Date: 2014-02-28